Antonio S. Montecalvo
CIK 1759261 · Vice President, Health Policy · last filed 2026-03-03
Antonio S. Montecalvo is a Vice President, Health Policy who has filed 18 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ORGO, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$902.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $296.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ORGO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
85 DAN ROAD
CANTON, MA 02021
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORGO | Vice President, Health Policy | 230,016 | $1.29 | $296.7K | -$902.7K | 17 | 2026-03-03 |
| Organogenesis Holdings Inc. (AHPAW) Delisted | VP Health Policy & Contracting | 8,482 | $0.69 | $5.9K | $0 | 1 | 2018-12-12 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | ORGO | Mixed | +7,552 | -$14.5K | EDGAR |
| 2026-02-20 | ORGO | Mixed | +48,102 | -$14.4K | EDGAR |
| 2026-02-18 | ORGO | Tax (F) | −18,619 | -$69.4K | EDGAR |
| 2025-02-21 | ORGO | Grant (A) | +42,493 | $0 | EDGAR |
| 2025-02-19 | ORGO | Tax (F) | −14,081 | -$52.1K | EDGAR |
| 2024-04-03 | ORGO | Tax (F) | −1,752 | -$4.9K | EDGAR |
| 2024-02-23 | ORGO | Grant (A) | +43,732 | $0 | EDGAR |
| 2024-02-20 | ORGO | Tax (F) | −10,628 | -$39.0K | EDGAR |
| 2023-04-04 | ORGO | Tax (F) | −2,097 | -$4.5K | EDGAR |
| 2023-02-24 | ORGO | Grant (A) | +99,428 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.